PT101079A - Processo para a preparacao de esteres prolinaboronatos - Google Patents

Processo para a preparacao de esteres prolinaboronatos Download PDF

Info

Publication number
PT101079A
PT101079A PT101079A PT10107992A PT101079A PT 101079 A PT101079 A PT 101079A PT 101079 A PT101079 A PT 101079A PT 10107992 A PT10107992 A PT 10107992A PT 101079 A PT101079 A PT 101079A
Authority
PT
Portugal
Prior art keywords
formula
pinanediol
group
compound
boronate
Prior art date
Application number
PT101079A
Other languages
English (en)
Portuguese (pt)
Inventor
Julian Adams
Roger Snow
Terence A Kelly
Simon Coutts
Clark Perry
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of PT101079A publication Critical patent/PT101079A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/025—Boronic and borinic acid compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
PT101079A 1991-11-22 1992-11-19 Processo para a preparacao de esteres prolinaboronatos PT101079A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79614891A 1991-11-22 1991-11-22
US93619892A 1992-08-26 1992-08-26

Publications (1)

Publication Number Publication Date
PT101079A true PT101079A (pt) 1994-02-28

Family

ID=27121696

Family Applications (1)

Application Number Title Priority Date Filing Date
PT101079A PT101079A (pt) 1991-11-22 1992-11-19 Processo para a preparacao de esteres prolinaboronatos

Country Status (17)

Country Link
EP (1) EP0641347A1 (env)
JP (1) JPH07501078A (env)
CN (1) CN1073946A (env)
AU (1) AU661362B2 (env)
CA (1) CA2123128A1 (env)
CZ (1) CZ124494A3 (env)
FI (1) FI942345A0 (env)
HU (1) HUT67937A (env)
IL (1) IL103817A0 (env)
MX (1) MX9206628A (env)
NO (1) NO941905L (env)
NZ (1) NZ245207A (env)
PT (1) PT101079A (env)
SI (1) SI9200332A (env)
SK (1) SK59294A3 (env)
TW (1) TW232697B (env)
WO (1) WO1993010127A1 (env)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6825169B1 (en) 1991-10-22 2004-11-30 Trustees Of Tufts College Inhibitors of dipeptidyl-aminopeptidase type IV
US5965532A (en) 1996-06-28 1999-10-12 Trustees Of Tufts College Multivalent compounds for crosslinking receptors and uses thereof
US6040145A (en) 1997-05-07 2000-03-21 Tufts University Potentiation of the immune response
US6100234A (en) 1997-05-07 2000-08-08 Tufts University Treatment of HIV
CA2304206A1 (en) 1997-09-29 1999-04-08 Point Therapeutics, Inc. Stimulation of hematopoietic cells in vitro
MY132924A (en) 1998-05-04 2007-10-31 Point Therapeutics Inc Hematopoietic stimulation
WO1999062914A1 (en) 1998-06-05 1999-12-09 Point Therapeutics, Inc. Cyclic boroproline compounds
US6979697B1 (en) 1998-08-21 2005-12-27 Point Therapeutics, Inc. Regulation of substrate activity
US6890904B1 (en) 1999-05-25 2005-05-10 Point Therapeutics, Inc. Anti-tumor agents
JP2003523396A (ja) * 2000-02-25 2003-08-05 ノボ ノルディスク アクティーゼルスカブ ベータ細胞変性の抑制
AU2003218969A1 (en) * 2002-02-01 2003-09-02 Probiodrug Ag Modulation of t lymphocytes using dp iv inhibitors
EP1689757B1 (en) 2003-11-12 2014-08-27 Phenomix Corporation Heterocyclic boronic acid compounds
US7317109B2 (en) 2003-11-12 2008-01-08 Phenomix Corporation Pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV
US7576121B2 (en) 2003-11-12 2009-08-18 Phenomix Corporation Pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV
US7767828B2 (en) 2003-11-12 2010-08-03 Phenomix Corporation Methyl and ethyl substituted pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV
KR20150132601A (ko) 2003-11-17 2015-11-25 노파르티스 아게 디펩티딜 펩티다제 ⅳ 억제제의 용도
EP3366283B1 (en) 2004-01-20 2021-09-01 Novartis AG Direct compression formulation and process
AR049631A1 (es) * 2004-04-27 2006-08-23 Wyeth Corp Proceso de acoplamiento para la generacion de derivados reactivos de pirrol -2- carbonitrilo n- sustituidos con contenido de boro para producir biarilos
DOP2006000008A (es) 2005-01-10 2006-08-31 Arena Pharm Inc Terapia combinada para el tratamiento de la diabetes y afecciones relacionadas y para el tratamiento de afecciones que mejoran mediante un incremento de la concentración sanguínea de glp-1
EP1943257A2 (en) 2005-05-19 2008-07-16 Genentech, Inc. Fibroblast activation protein inhibitor compounds and methods
US7825139B2 (en) 2005-05-25 2010-11-02 Forest Laboratories Holdings Limited (BM) Compounds and methods for selective inhibition of dipeptidyl peptidase-IV
CN1331835C (zh) * 2005-10-18 2007-08-15 武汉大学 光活性β－羟基酮的制备方法
JP5270369B2 (ja) * 2005-12-19 2013-08-21 タフツ ユニバーシティー／トラスティーズ オブ タフツ カレッジ ソフトプロテアーゼ抑制剤およびそのプロソフト型
ES2354390T3 (es) 2006-04-11 2011-03-14 Arena Pharmaceuticals, Inc. Procedimientos de uso del receptor gpr119 para identificar compuestos útiles para aumentar la masa ósea en un individuo.
PE20071221A1 (es) 2006-04-11 2007-12-14 Arena Pharm Inc Agonistas del receptor gpr119 en metodos para aumentar la masa osea y para tratar la osteoporosis y otras afecciones caracterizadas por masa osea baja, y la terapia combinada relacionada a estos agonistas
EP2146210A1 (en) 2008-04-07 2010-01-20 Arena Pharmaceuticals, Inc. Methods of using A G protein-coupled receptor to identify peptide YY (PYY) secretagogues and compounds useful in the treatment of conditions modulated by PYY
HRP20150592T4 (hr) * 2008-06-17 2025-02-14 Millennium Pharmaceuticals, Inc Organoborni esterski spojevi i njihove farmaceutske kompozicije
AR077642A1 (es) 2009-07-09 2011-09-14 Arena Pharm Inc Moduladores del metabolismo y el tratamiento de trastornos relacionados con el mismo
MX2012011631A (es) 2010-04-06 2013-01-18 Arena Pharm Inc Moduladores del receptor gpr119 y el tratamiento de trastornos relacionados con el mismo.
MX2013003184A (es) 2010-09-22 2013-06-07 Arena Pharm Inc Moduladores del receptor gpr119 y el tratamiento de transtornos relacionados con el mismo.
WO2012135570A1 (en) 2011-04-01 2012-10-04 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2012145361A1 (en) 2011-04-19 2012-10-26 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
US20140038889A1 (en) 2011-04-22 2014-02-06 Arena Pharmaceuticals, Inc. Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
US20140051714A1 (en) 2011-04-22 2014-02-20 Arena Pharmaceuticals, Inc. Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
WO2012170702A1 (en) 2011-06-08 2012-12-13 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2013055910A1 (en) 2011-10-12 2013-04-18 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2014074668A1 (en) 2012-11-08 2014-05-15 Arena Pharmaceuticals, Inc. Modulators of gpr119 and the treatment of disorders related thereto
US9523687B2 (en) 2014-02-28 2016-12-20 Institut Pasteur Levels of CXCL 10/IP-10 forms and soluble CD26/DPPIV activity as early predictive biomarkers for HIV/SIV associated mucosal inflammation and progression towards AIDS
SG10202003693RA (en) 2014-05-20 2020-05-28 Millennium Pharm Inc Boron-containing proteasome inhibitors for use after primary cancer therapy
HK1249847A1 (zh) 2015-03-09 2018-11-16 Intekrin Therapeutics, Inc. 用於治疗非酒精性脂肪肝疾病和/或脂肪营养不良的方法
WO2018162722A1 (en) 2017-03-09 2018-09-13 Deutsches Institut Für Ernährungsforschung Potsdam-Rehbrücke Dpp-4 inhibitors for use in treating bone fractures
KR20200036808A (ko) 2017-04-03 2020-04-07 코히러스 바이오사이언시스, 인크. 진행성 핵상 마비 치료를 위한 PPARγ 작용제
CN108047257B (zh) * 2017-12-17 2020-03-13 沧州普瑞东方科技有限公司 一种手性n-boc-吡咯烷-2-硼酸的制备工艺
PL3755681T3 (pl) * 2018-02-20 2022-11-28 Otsuka Pharmaceutical Co., Ltd. Sposób wytwarzania 4-boronofenyloalaniny
CN110452258B (zh) * 2019-09-03 2021-01-01 上海馨远医药科技有限公司 一种二肽缬氨酸硼脯氨酸盐的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4935493A (en) * 1987-10-06 1990-06-19 E. I. Du Pont De Nemours And Company Protease inhibitors
ES2099158T3 (es) * 1990-04-14 1997-05-16 New England Medical Center Inc Tratamiento del rechazo de trasplantes o de enfermedades autoinmunitarias y complejo de la formula general x-pro-y-boropro asociada al mismo.
GB9017694D0 (en) * 1990-08-13 1990-09-26 Sandoz Ltd Improvements in or relating to organic chemistry

Also Published As

Publication number Publication date
NZ245207A (en) 1994-07-26
FI942345A7 (fi) 1994-05-20
SI9200332A (en) 1993-06-30
CN1073946A (zh) 1993-07-07
SK59294A3 (en) 1995-02-08
MX9206628A (es) 1993-05-01
IL103817A0 (en) 1993-04-04
NO941905L (no) 1994-07-14
TW232697B (env) 1994-10-21
CZ124494A3 (en) 1995-07-12
WO1993010127A1 (en) 1993-05-27
HUT67937A (en) 1995-05-29
AU661362B2 (en) 1995-07-20
NO941905D0 (no) 1994-05-20
JPH07501078A (ja) 1995-02-02
FI942345A0 (fi) 1994-05-20
CA2123128A1 (en) 1993-05-27
EP0641347A1 (en) 1995-03-08
HU9401350D0 (en) 1994-08-29
AU3136893A (en) 1993-06-15

Similar Documents

Publication Publication Date Title
AU661362B2 (en) Method for making a prolineboronate ester
EP4008721B1 (en) Synthesis of boronic ester and acid compounds
Kinder et al. Acylamido boronic acids and difluoroborane analogs of amino acids: potent inhibitors of chymotrypsin and elastase
Katz et al. Episelection: novel Ki. apprx. nanomolar inhibitors of serine proteases selected by binding or chemistry on an enzyme surface
JP7086987B2 (ja) 銅およびニッケル触媒による脱炭酸ホウ素化反応
Jagannathan et al. Synthesis of boronic acid analogues of α-amino acids by introducing side chains as electrophiles
US4853476A (en) Phosphorus containing compounds as inhibitors of enkephalinases
KR890000769B1 (ko) 프롤린 유도체의 제법
US5393912A (en) D-myo-inositol 1,4,5-trisphosphate analogues
KR890000770B1 (ko) 프롤린 유도체의 제법
Terzis et al. Preparation of pseudo-arsonolipids: 2-acyloxypropane-1, 3-bis (arsonic acids). The crystal structure of 2-hydroxypropane-1, 3-bis (arsonic acid)
Kuder et al. Synthesis of a triply phosphorylated pentapeptide from human τ-protein
JPS5940839B2 (ja) 混合酸型１，２−ジアシル−３−グリセリルホスホリルコリン類の製法
JP2665633B2 (ja) グリセロール誘導体
EP0050799B1 (en) New processes for the production of di-alkyl esters and optically active mono-alkyl esters of 3-aminoglutaric acid
HK40066099B (en) Synthesis of boronic ester and acid compounds
HK40066099A (en) Synthesis of boronic ester and acid compounds
Phelps et al. Synthesis of chromophoric dehydro analog of leucine enkephalin
KR101093417B1 (ko) 트리플루오로아세틸 숙신이미드에스터의 제조방법
AU2011265442B2 (en) Synthesis of boronic ester and acid compounds
KR100255040B1 (ko) 아미노산실릴에스터를 이용한 d-(-)-펜토락톤의제조방법
Snider et al. Synthesis of Deoxytabtoxinine-β-Lactam
Fabry-Asztalos Asymmetric synthesis of organoboron compounds bearing peptides and other nitrogen containing substituents
Horenstein Total synthesis of Tunichrome An-1: A reducing blood pigment found in the vanadium sequestering tunicate Ascidia nigra
Lee Inhibition and reaction mechanism of acetylcholinesterase-catalyzed hydrolysis of thioesters

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19930715

FC3A Refusal

Effective date: 19990607